Synopsis The incidence of cesarean scar pregnancy (CSP) has substantially increased worldwide. Uterine artery chemoembolization combined with curettage was found to be an effective fertility-sparing treatment model for cesarean scar pregnancy. The present study aims to evaluate the efficacy and long-term prognosis of uterine artery chemoembolization (UACE) combined with curettage for treatment of cesarean scar pregnancy (CSP).
This week’s “MED FACT” discusses a clinical trial from Journal of Gynecology and Obstetrics, “Retrospective study of patients with cesarean scar pregnancies treated by uterine artery chemoembolization and curettage”. Authors: Yang Li, Lingjia Lu, Wenxian Wang, Jin Sun, Xinmei Zhang, Xiufeng Huang Key Takeaways UACE combined with curettage is an effective fertility-sparing treatment for CSP. Objective: The present study aims to evaluate the efficacy and long-term…
